Arix Bioscience PLC | Finanzwire

PRESS RELEASE

published on 07/17/2023 at 16:00, 1 year 4 months ago

Holding(s) in Company
PRESS RELEASE

published on 07/13/2023 at 08:01, 1 year 4 months ago

Arix Announces Strategic Review
PRESS RELEASE

published on 07/13/2023 at 08:00, 1 year 4 months ago

Unaudited NAV for June 2023
PRESS RELEASE

published on 06/23/2023 at 15:03, 1 year 5 months ago

Portfolio company Disc Medicine raises $157.8 million in public offering
PRESS RELEASE

published on 06/09/2023 at 15:53, 1 year 5 months ago

Portfolio company Disc Medicine presents positive initial data from Phase 2 BEACON trial at EHA
PRESS RELEASE

published on 06/09/2023 at 08:00, 1 year 5 months ago

Unaudited NAV for May 2023
PRESS RELEASE

published on 05/24/2023 at 08:00, 1 year 5 months ago

Correction: Result of Annual General Meeting
PRESS RELEASE

published on 05/23/2023 at 17:30, 1 year 6 months ago

Result of Annual General Meeting
PRESS RELEASE

published on 05/16/2023 at 17:36, 1 year 6 months ago

Portfolio company Ensoma announces closing of Series B Extension
PRESS RELEASE

published on 05/12/2023 at 08:00, 1 year 6 months ago

Unaudited NAV for April 2023

Published on 11/22/2024 at 18:14, 1 day 8 hours ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 18:00, 1 day 9 hours ago

Holding(s) in Company
Published on 11/22/2024 at 17:53, 1 day 9 hours ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 1 day 10 hours ago

EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/22/2024 at 16:00, 1 day 11 hours ago

Proposed cancellation of admission to trading

News